Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov-Dec;21(6):1049-52.

Photodynamic therapy versus thermal laser photocoagulation for the treatment of recurrent choroidal neovascularization due to AMD

Affiliations
  • PMID: 18210754
Free article

Photodynamic therapy versus thermal laser photocoagulation for the treatment of recurrent choroidal neovascularization due to AMD

Anastasios Kallitsis et al. In Vivo. 2007 Nov-Dec.
Free article

Abstract

The aim of this study was to compare the effectiveness of thermal laser photocoagulation (TLP) to that of photodynamic therapy (PDT) for the treatment of recurrent choroidal neovascularization (CNV) in patients with age-related macular degeneration (AMD).

Patients and methods: We prospectively studied 38 patients (40 eyes) with AMD presented with recurrent CNV after TLP. The study eyes were assigned to one of the two groups according to their treatment (repetition of TLP or PDT). PDT was performed according to the standard protocol. The follow-up time ranged from 9 months to 9 years.

Results: The mean best-corrected visual acuity (VA) was statistically significantly lower compared to that of the baseline in both groups of the study. There were no statistically significant differences between the two groups with regard to the stabilization, improvement or decline of the best-corrected VA.

Conclusion: According to our results TLP and PDT are equally ineffective for the treatment of recurrent CNV in patients with AMD.

PubMed Disclaimer

LinkOut - more resources